Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

From Chemistry to the Clinic: Pathways for Drug Discovery and Development. Part 1: Target Identification and Validation in Cancer Drug Discovery

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Introduction
Dr. John T. Hunt
Bristol-Myers Squibb Company, Princeton, NJ
from 2005 Annual Meeting on April 16, 2005 9:00 AM-9:05 AM
Pathway-oriented Oncology Target Discovery
Dr. Matt V. Lorenzi
Bristol-Myers Squibb Company, Princeton, NJ
from 2005 Annual Meeting on April 16, 2005 9:05 AM-9:40 AM
ICG-001: A Novel Chemogenomic Tool to Investigate the Wnt Pathway in Cancer
Dr. Michael Kahn
University of Washington, Seattle, WA
from 2005 Annual Meeting on April 16, 2005 10:25 AM-10:50 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3